Testing effectiveness (Phase 2)Not Yet RecruitingNCT06783153
What this trial is testing
Efficacy and Safety of Adjunctive Use of Rifaximin In Preventing Radiotherapy-induced Diarrhea in Cancer Patients
Who this might be right for
Radiotherapy Induced DiarrheaAcute Radiation EnteritisProstate Cancer+5 more
Mansoura University 80